Stay updated on Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:22:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has removed extensive details about a Phase II study involving pembrolizumab for NSCLC patients, including specific inclusion and exclusion criteria, while adding a new identifier and a revision number.
    Difference
    36%
    Check dated 2025-04-16T20:36:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has updated the date to March 14, 2025, and indicates that results have been submitted, replacing the previous indication of no results posted. Additionally, the revision number has changed from v2.14.3 to v2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T14:48:19.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The webpage has been updated with new dates and statuses, indicating a shift in the timeline for events or updates, specifically moving from 2024 to 2025.
    Difference
    2%
    Check dated 2025-03-18T14:34:03.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:15:38.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:53:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.